Topics

Keeping Track: Biosimilars, Novel Approvals, And Ebola

16:39 EST 10 Nov 2019 | SCRIP

The latest drug development news and highlights from our US FDA Performance Tracker include a Neulasta biosimilar approval for Sandoz...

      

Related Stories

 

Original Article: Keeping Track: Biosimilars, Novel Approvals, And Ebola

NEXT ARTICLE

More From BioPortfolio on "Keeping Track: Biosimilars, Novel Approvals, And Ebola"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...